Cellebrite DI Ltd. (CLBT)
| Market Cap | 4.19B |
| Revenue (ttm) | 455.90M |
| Net Income (ttm) | 76.33M |
| Shares Out | 244.47M |
| EPS (ttm) | 0.31 |
| PE Ratio | 54.76 |
| Forward PE | 32.66 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,134,084 |
| Open | 16.71 |
| Previous Close | 16.86 |
| Day's Range | 16.57 - 17.17 |
| 52-Week Range | 13.10 - 26.30 |
| Beta | 1.28 |
| Analysts | Strong Buy |
| Price Target | 24.40 (+42.36%) |
| Earnings Date | Nov 12, 2025 |
About CLBT
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurre... [Read more]
Financial Performance
In 2024, Cellebrite DI's revenue was $401.20 million, an increase of 23.41% compared to the previous year's $325.11 million. Losses were -$283.01 million, 249.0% more than in 2023.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CLBT stock is "Strong Buy." The 12-month stock price target is $24.4, which is an increase of 42.36% from the latest price.
News
Cellebrite DI: Strong Q3, But Valuation And Technical Issues Could Weigh On The Stock (Rating Downgrade)
Cellebrite DI remains a long-term growth story, despite recent volatility and a modest stock decline since November 2024. CLBT's Q3 2025 earnings beat analyst expectations, with revenue up 18% year-ov...
Should Investors Buy Shares of Cellebrite Alongside Portolan Capital as They Double Down on the Stock?
Portolan Capital increased its Cellebrite position by 1,407,818 shares, worth an estimated $28.65 million. The transaction equates to approximately 1.20% of 13F reportable assets under management (AUM...
Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter
Delaware-based Ashford Capital Management increased its position Cellebrite by 434,615 shares during the third quarter, adding an estimated $11.3 million in value to its stake. At quarter-end, Ashford...
Why Cellebrite Stock Is Skyrocketing Today
Cellebrite topped Wall Street's sales and earnings expectations for the third quarter. The company also raised its full-year guidance.
Cellebrite DI Ltd. (CLBT) Q3 2025 Earnings Call Transcript
Cellebrite DI Ltd. ( CLBT) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Andrew Kramer - Vice President of Investor Relations Thomas Hogan - CEO & Director David Barter - C...
Cellebrite Announces Third-Quarter 2025 Results
ARR grew 19% to $439.8 million; Revenue grew 18% to $126.0 million Net income of $20.2 million supports non-GAAP net income of $36.9 million and adjusted EBITDA of $37.7 million, 29.9% adjusted EBITDA...
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (Nasdaq: CLBT), global leader in premier Digital Investigative and Intelligence solutions for the public...
Cellebrite to Report Third-Quarter 2025 Financial Results on November 12, 2025
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, ...
Cellebrite Expands Market Reach with Innovations in Agentic AI, Cloud and Device Virtualization for the Company's Autumn 2025 Release
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, ...
Cellebrite: Long-Term Growth Is Now Much Clearer (Rating Upgrade)
Upgrading Cellebrite to buy as leadership uncertainty is resolved and new CEO/CFO bring proven execution experience. Rapid adoption of Inseyets and Guardian platforms, with SaaS/cloud ARR growing >50%...
Cellebrite DI Ltd. (CLBT) Q2 2025 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants Adam H.
Cellebrite Begins Its Next Chapter
Here's our initial take on Cellebrite DI's (CLBT 0.57%) financial report.
Cellebrite Announces Second-Quarter 2025 Results
Thomas E. Hogan Named CEO ARR grew 21% to $418.9 million; Revenue grew 18% to $ 113.3 million Net income of $19.5 million supports non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 mil...
Cellebrite DI: Market Apathy Vs. Strong Fundamentals
Cellebrite offers a strong risk-reward profile after recent corrections, supported by robust execution and financials despite weak sentiment and macro headwinds. The company's leadership in digital fo...
U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO
TYSONS CORNER, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the U.S....
Cellebrite Names David Barter Chief Financial Officer
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, ...
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the expa...
Cellebrite to Acquire Corellium
Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing Combination Delivers Unmatched Innovation in Arm-based Vulnerab...
Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, t...
Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings
Lifecore, Burford, KKR, PAR, and Cellebrite are well-positioned despite trade policy and tariff headwinds, each with unique catalysts for growth. KKR stands out for its asset growth, brand strength, a...
Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen ...
Cellebrite Announces First-Quarter 2025 Results
First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations
AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors,...
10 Winners Awarded “Justies” at Cellebrite's First-Ever Digital Justice Awards
The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebra...